Metadata
| Source Table | grants |
| Source ID | hRWZFQEQAr |
| Description | to Eradavir, USD 250000, 2025-03 |
| Source URL | coefficientgiving.org/funds/ |
| Parent | Coefficient Giving |
| Children | — |
| Created | Mar 12, 2026, 5:54 AM |
| Updated | Mar 22, 2026, 2:59 AM |
| Synced | Mar 19, 2026, 8:57 PM |
Record Data
id | hRWZFQEQAr |
organizationId | Coefficient Giving(organization) |
granteeId | Eradavir |
orgEntityId | Coefficient Giving(organization) |
orgDisplayName | — |
granteeEntityId | — |
granteeDisplayName | Eradavir |
name | Eradavir — Influenza Treatment RCT |
amount | 250000 |
currency | USD |
period | — |
date | 2025-03 |
status | — |
source | coefficientgiving.org/funds/ |
notes | [Scientific Research] Open Philanthropy recommended an investment of $250,000 in Eradavir to support a randomized controlled trial of a drug for treating influenza. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influenza antiviral, zanami… |
programId | B4pZkOtjSk |
dataSourceId | — |
Source Check Verdicts
confirmed95% confidence
Last checked: 4/9/2026
[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Debug info
Thing ID: hRWZFQEQAr
Source Table: grants
Source ID: hRWZFQEQAr
Parent Thing ID: sid_ULjDXpSLCI